Ranitidine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Ranitidine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

RANITIDINE HYDROCHLORIDE DESCRIPTION



Ranitidine Hydrochloride











CLINICAL PHARMACOLOGY



PHARMACOKINETICS
























PHARMACODYNAMICS

PHARMACODYNAMICS


























































































INDICATIONS & USAGE











RANITIDINE HYDROCHLORIDE CONTRAINDICATIONS



PRECAUTIONS







LABORATORY TESTS

LABORATORY TESTS


DRUG INTERACTIONS













CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY




PREGNANCY






NURSING MOTHERS



PEDIATRIC USE

PEDIATRIC USE





GERIATRIC USE

GERIATRIC USE



RANITIDINE HYDROCHLORIDE ADVERSE REACTIONS

ADVERSE REACTIONS
































OVERDOSAGE

OVERDOSAGE




DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION











































PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Ranitidine Hydrochloride

Ranitidine Hydrochloride

Ranitidine Hydrochloride

Ranitidine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-165(NDC:60505-0025-8)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
RANITIDINE HYDROCHLORIDE RANITIDINE 150 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
HYPROMELLOSES
MAGNESIUM STEARATE
maltodextrin
cellulose, microcrystalline
POLYDEXTROSE
polyethylene glycol
SODIUM BICARBONATE
talc
titanium dioxide
TRIETHYL CITRATE

Product Characteristics

Color Size Imprint Code Shape
white 8 mm RAN;150;APO ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-165-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074680 2011-04-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.